Press release

dsm-firmenich and Indena to debut pioneering biotic and botanical combination concepts at Vitafoods Europe 2024

Kaiseraugst (Switzerland), Heerlen (Netherlands), May 2024

dsm-firmenich, innovators in nutrition, health, and beauty, and Indena, the leading developer of high-quality and scientifically sound active botanical ingredients for the pharmaceutical and health food market, will introduce dietary supplement solutions combining biotics with botanicals in enjoyable delivery formats, offering an enhanced flavor and taste experience, at Vitafoods Europe 2024.  

The new concepts mark the next step in dsm-firmenich and Indena’s partnership, targeting consumer health priorities such as Health from the Gut, Brain Health and Healthy Aging to create next-generation dietary supplement solutions that contribute to drive the future of nutraceuticals.

The jointly-developed concepts combine biotics, essential nutrients and active botanical extracts to target a range of health areas while elevating the consumer experience through delicious, easy-to-use formats such as gummies and oral dispersible granules.

In the Health from the Gut space, the two companies have developed two different dietary supplement gummy solutions. The first development supports the gut-brain axis with Humiome® Post LB (dsm-firmenich’s postbiotic) and the calming agent Relissa™ (an innovative Melissa officinalis L. extract formulated with Indena Phytosome ™ technology). The second solution supports microbiome balance by combining Humiome® Post LB with CUBO™ (a combination of Curcumin Phytosome™ and Boswellia Phytosome™).

Furthermore, dsm-firmenich and Indena will  introduce a range of solutions for brain health and healthy aging, featuring essential nutrients and botanicals including Virtiva® Plus, a unique synergistic combination of Ginkgo biloba L. extract with phosphatidylserine showing a clinically validated nootropic effect; life’s®OMEGA, dsm-firmenich's algal-sourced omega-3 ingredient; Quali®-B12 vitamin B12 ingredient; Quercefit® formulated with Indena Phytosome™ technology to optimize biological performance; and ampli-D®, an innovative and more bioavailable vitamin D ingredient shown to increase levels of the ‘sunshine vitamin’ in a much shorter timeframe.

"We are thrilled to partner with Indena to showcase these new concepts at Vitafoods," says Francois Scheffler, Head of Global Marketing and Business Development at dsm-firmenich. "By combining our strengths in science-backed biotics and essential nutrients with Indena's expertise in botanical extracts, we are able to create next-generation dietary supplement solutions that meet the increasingly sophisticated demands of today's health-conscious consumers, with a focus on scientific substantiation, maximum efficacy and enhancing experiences through flavor and taste."

"This new range represents another significant step forward in our continuous mission to promote health through nature," adds Daniele Giavini, Managing Director at Indena. "Together with dsm-firmenich, we are committed to generating some specific high-quality, evidence-based solutions that address certain key health areas, such as health from the gut, digestive comfort, cognitive performance and healthy aging. Our partnership will continue to ideate additional cutting-edge concepts that aim to answer market needs with highly innovative products that are scientifically studied, clinically tested and technologically advanced.” 

“Novel delivery formats like gummies, gels and powder sticks are gaining momentum with consumers looking for more enjoyable, convenient wellness routines,” says Jerome Barra, VP Taste Global Marketing and Business Development at dsm-firmenich. “The new concepts demonstrate our unique taste and flavor sensorial expertise in helping customers mask ingredient off-notes and crafting flavor profiles that deliver deeper experiential connections to consumers, making it possible to address the most pressing health needs sustainably.”

Both companies are also committed to driving progress towards the UN’s Sustainable Development Goals. All projects within the strategic partnership aim to put sustainability first – from raw materials sourcing to production and marketing – with a focus on environmental impact, use of renewable energies and building a more circular economy.

To learn more about the next-generation dietary supplements solution developed by dsm-firmenich and Indena, book a meeting with the dsm-firmenich team at Vitafoods Europe 2024 click here.

About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.

About Indena
Indena is the leading company dedicated to the identification, development and production of high quality active principles derived from plants, for use in the pharmaceutical and health food industries. Backed up by a century of botanical experience, the company owns 100 patent families, has published more than 1000 scientific studies and co-operates with the world’s most prestigious universities and private research institutions. Indena employs over 900 staff, investing a significant amount of its annual turnover in research, making this activity the key to its success. Headquartered in Milan, Indena has 4 production sites and 5 international branches throughout the world and manages sales in more than 80 countries. The company's experts communicate and interact constantly with the major international regulatory authorities and cooperate on the update of all the main pharmacopoeias.

For more information




Investors email

Issuing Agency

Rebecca Hawthorne

BDB agency

Tel. +44 (0) 161 925 4700

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.